Arix Bioscience Plc Director/PDMR Shareholding (9556V)
17 December 2021 - 6:00PM
UK Regulatory
TIDMARIX
RNS Number : 9556V
Arix Bioscience Plc
17 December 2021
Arix Bioscience plc
Director/PDMR Shareholdings
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Robert Lyne
---------------------------------------------- --------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------
a) Position/status CEO and General Counsel
---------------------------------------------- --------------------------------------------
b) Initial notification /Amendment Initial Notification
---------------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------------
a) Name Arix Bioscience plc
---------------------------------------------- --------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
---------------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
--------------------------------------------------------------------------------------------
a) Description of the financial Arix Bioscience plc Ordinary shares of
instrument, type of instrument 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s)
Price(s) Volume(s)
1 20.00p 41,666.00
d) Aggregated information
- Aggregated volume N/A single transaction
- Price GBP49,999.20
e) Date of the transaction 16 December 2021
---------------------------------------------- --------------------------------------------
f) Place of the transaction London Stock Exchange
---------------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Peregrine Moncreiffe
---------------------------------------------- --------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director and Chair of
the Board
---------------------------------------------- --------------------------------------------
b) Initial notification /Amendment Initial Notification
---------------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------------
a) Name Arix Bioscience plc
---------------------------------------------- --------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
---------------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
--------------------------------------------------------------------------------------------
a) Description of the financial Arix Bioscience plc Ordinary shares of
instrument, type of instrument 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s)
Price(s) Volume(s)
1 19.00p 84,000.00
d) Aggregated information
- Aggregated volume N/A single transaction
- Price GBP99,959.98
e) Date of the transaction 16 December 2021
---------------------------------------------- --------------------------------------------
f) Place of the transaction London Stock Exchange
---------------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Sir Michael Bunbury
---------------------------------------------- ----------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director and Senior Independent
Director (SID)
---------------------------------------------- ----------------------------------------------------
b) Initial notification /Amendment Initial Notification
---------------------------------------------- ----------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------
a) Name Arix Bioscience plc
---------------------------------------------- ----------------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
---------------------------------------------- ----------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
----------------------------------------------------------------------------------------------------
a) Description of the financial Arix Bioscience plc Ordinary shares of
instrument, type of instrument 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s)
Price(s) Volume(s)
1 19.00p 40,000.00
d) Aggregated information
- Aggregated volume N/A single transaction
- Price GBP47,600.00
e) Date of the transaction 16 December 2021
---------------------------------------------- ----------------------------------------------------
f) Place of the transaction London Stock Exchange
---------------------------------------------- ----------------------------------------------------
For further information please contact:
Derringtons Limited, Company Secretary
+44 20 8819 6486
Ends.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHDQLFFFLLXFBQ
(END) Dow Jones Newswires
December 17, 2021 02:00 ET (07:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2023 to Apr 2024
